Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Tresiba Solid As Novo Nordisk Plots Japan Growth

This article was originally published in PharmAsia News

Executive Summary

Novo Nordisk has had its best year ever in sales terms in Japan, where its subsidiary is benefiting mainly from the strong performance of basal insulin preparation Tresiba.



Related Companies